|
Market Closed -
Australian S.E.
01:10:22 2026-10-23 am EDT
|
5-day change | 1st Jan Change | ||
| 0.3350 AUD | -2.90% |
|
+15.52% | -48.46% |
| Market Cap | 102M 72.04M 64.34M 59.43M 53.86M 101M 6.84B 715M 283M 3.58B 270M 265M 11.3B | P/E 2027 * |
-3.94x | P/E 2028 * | 3.02x |
|---|---|---|---|---|---|
| Enterprise Value | 127M 89.6M 80.01M 73.92M 66.99M 125M 8.51B 890M 352M 4.46B 336M 329M 14.05B | EV / Sales 2027 * |
10.2x | EV / Sales 2028 * | 1x |
| Free-Float |
62.73% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| RCE | Delayed | |
Boerse Muenchen
| R9Q | Real-time | |
|
Deutsche Boerse AG
| R9Q | Delayed | |
|
Börse Stuttgart
| R9Q | Delayed | |
|
Tradegate
| R9Q | Real-time |
| 1 day | -2.90% | ||
| 1 week | +15.52% | ||
| Current month | +6.35% | ||
| 3 months | -6.94% | ||
| 6 months | -34.31% | ||
| Current year | -48.46% |
| 1 week | 0.28 |  | 0.36 |
| 1 month | 0.26 | | 0.36 |
| Current year | 0.26 | | 0.73 |
| 1 year | 0.26 | | 0.73 |
| 3 years | 0.26 | | 0.73 |
| 5 years | 0.26 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 2020-08-27 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 2012-09-30 |
James Graham
BRD | Director/Board Member | - | 2012-04-30 |
| Director/Board Member | - | 2022-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/31/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 7/31/26 | Buy | Director | 75,000 | 0.0250% | ||
| 7/31/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.90% | +15.52% | -19.28% | -23.86% | 72.04M | |
| -2.54% | +1.31% | +55.10% | +120.84% | 1,135B | |
| -1.42% | +3.23% | +37.07% | +74.26% | 636B | |
| +0.16% | +0.08% | +25.14% | +97.36% | 505B | |
| -0.31% | +3.09% | +43.92% | +64.55% | 378B | |
| -1.34% | -0.47% | +66.63% | +40.56% | 358B | |
| -0.68% | +2.65% | +22.46% | +51.48% | 295B | |
| -1.20% | +3.04% | +2.62% | +26.97% | 266B | |
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | |
| -0.73% | -0.10% | +29.24% | +101.19% | 193B | |
| Average | -0.89% | +3.50% | +31.29% | +61.42% | 400.44B | |
| Weighted average by Cap. | -0.26% | +2.66% | +40.99% | +82.13% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 12.5M 8.79M 7.85M 7.25M 6.57M 12.29M 834M 87.25M 34.54M 437M 32.98M 32.28M 1.38B | 54.3M 38.19M 34.1M 31.51M 28.55M 53.42M 3.63B 379M 150M 1.9B 143M 140M 5.99B |
| Net income | -25.1M -17.65M -15.76M -14.56M -13.2M -24.69M -1.68B -175M -69.38M -878M -66.25M -64.84M -2.77B | 33.4M 23.49M 20.98M 19.38M 17.56M 32.86M 2.23B 233M 92.33M 1.17B 88.16M 86.29M 3.68B |
| Net Debt | 24.96M 17.56M 15.68M 14.48M 13.13M 24.56M 1.67B 174M 69.01M 873M 65.89M 64.49M 2.75B | -48.1M -33.83M -30.21M -27.91M -25.29M -47.32M -3.21B -336M -133M -1.68B -127M -124M -5.3B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | A$0.3350 | -2.90% | 126,535 |
| 26-10-22 | A$0.3450 | -2.82% | 69,173 |
| 26-10-21 | A$0.3550 | +1.43% | 203,787 |
| 26-10-20 | A$0.3500 | +20.69% | 744,674 |
| 26-10-19 | A$0.2900 | 0.00% | 93,370 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
